The round was led by Oak HC/FT with participation from Greco, SNR, and existing investors Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Research), and the Comprehensive Blood & Cancer Center. Funding will be used to expand the reach of ScopeAI, a system that increases clinical capacity and improves healthcare access..

本轮融资由Oak HC/FT领投，Greco、SNR以及现有投资者Y Combinator、Future Communities Capital、Jeff Dean（Google DeepMind和Google Research首席科学家）和Comprehensive Blood & Cancer Center参投。资金将用于扩大ScopeAI的覆盖范围，这是一套提升临床能力和改善医疗获取的系统。

Akido is pioneering a reimagined healthcare system with AI at its core; one that bridges artificial intelligence and empathy to bring exceptional healthcare to everyone. Its breakthrough technology unlocks the ability to transform the clinical experience, empowering providers and patients through an entirely new healthcare model.

Akido正在引领一个以人工智能为核心的医疗系统革新；这个系统将人工智能与同理心相结合，为每个人提供卓越的医疗服务。其突破性技术解锁了变革临床体验的能力，通过一个全新的医疗模式赋能医疗服务提供者和患者。

Founded in 2015, Akido was created out of the University of Southern California's Digital Health Lab with the idea that empowering government, healthcare, and nonprofit services with population-based data could help usher in a new era of preventive public health. Known for developing award-winning data and technology solutions, today Akido leverages its market-leading technology to power its bicoastal Akido Care medical network, which includes more than 240 providers and 90 clinics across both coasts and a patient base of nearly half a million..

2015年成立的Akido诞生于南加州大学数字健康实验室，其理念是通过基于人口的数据赋予政府、医疗保健和非营利服务机构力量，从而开启预防性公共卫生的新时代。Akido以开发屡获殊荣的数据和技术解决方案而闻名，如今利用其市场领先的技术支持横跨东西海岸的Akido Care医疗网络，该网络包括240多家供应商和90家诊所，覆盖两岸，患者群体接近50万人。